News
-
Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
11/8/2011
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced positive results from a study in patients with type 1 diabetes that receive their insulin therapy via pumps.
-
Radiant Research, Inc. Announces Launch Of A Cumulative Irritation Patch Study
9/20/2011
As part of their ongoing growth strategy, Radiant has been expanding its capabilities into the Consumer Products Testing arena.
-
Clinilabs And Ambulatory Monitoring Inc. Form Strategic Alliance - Merging The Most Respected Name In Activity Monitoring Equipment With The World's Leading Core
7/8/2011
Clinilabs, a full-service contract research organization that provides early-phase and specialty clinical drug development services to industry, has entered into a strategic alliance with Ambulatory Monitoring, Inc. (AMI), a medical device and service company.
This website uses cookies to ensure you get the best experience on our website. Learn more